NNPTE
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne Portfolio holdings
AUM
$846M
This Quarter Return
-0.14%
1 Year Return
+43.23%
3 Year Return
+287.81%
5 Year Return
+536.39%
10 Year Return
–
AUM
$485M
AUM Growth
+$485M
(-41%)
Cap. Flow
-$270M
Cap. Flow
% of AUM
-55.66%
Top 10 Holdings %
Top 10 Hldgs %
51.07%
Holding
63
New
11
Increased
9
Reduced
26
Closed
9
Top Buys
| 1 |
Waste Management
WM
|
$33.3M |
| 2 |
Axsome Therapeutics
AXSM
|
$29.4M |
| 3 |
XYZ
Block, Inc.
XYZ
|
$22.9M |
| 4 |
SWTX
SpringWorks Therapeutics
SWTX
|
$12.4M |
| 5 |
Linde
LIN
|
$11.5M |
Top Sells
| 1 |
Bank of America
BAC
|
$36.7M |
| 2 |
Southern Copper
SCCO
|
$36M |
| 3 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$31.8M |
| 4 |
JPMorgan Chase
JPM
|
$27.7M |
| 5 |
Wells Fargo
WFC
|
$27.7M |
Sector Composition
| 1 | Technology | 26.41% |
| 2 | Healthcare | 19.15% |
| 3 | Materials | 12.63% |
| 4 | Communication Services | 11.02% |
| 5 | Consumer Discretionary | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Linde
LIN
$222B
| $37.2M | 7.67% |
79,822
+24,709
| +45% | +$11.5M |
|
|
2
Waste Management
WM
$90.9B
| $33.3M | 6.87% |
+143,855
| New | +$33.3M |
|
|
3
Axsome Therapeutics
AXSM
$6.16B
| $33.3M | 6.87% |
285,494
+251,775
| +747% | +$29.4M |
|
4
Berkshire Hathaway Class B
BRK.B
$1.08T
| $26.9M | 5.55% |
50,517
+20,747
| +70% | +$11M |
|
|
XYZ
5
Block, Inc.
XYZ
$46.5B
| $22.9M | 4.73% |
+422,036
| New | +$22.9M |
|
6
Amazon
AMZN
$2.4T
| $21.5M | 4.44% |
113,071
-45,517
| -29% | -$8.66M |
|
7
Freeport-McMoran
FCX
$64.5B
| $21M | 4.34% |
555,093
| – | – |
|
8
Mercado Libre
MELI
$121B
| $18.3M | 3.78% |
9,393
-930
| -9% | -$1.81M |
|
9
Verizon
VZ
$185B
| $17M | 3.52% |
375,566
+71,177
| +23% | +$3.23M |
|
10
Meta Platforms (Facebook)
META
$1.85T
| $16M | 3.3% |
27,758
-16,001
| -37% | -$9.22M |
|
11
CrowdStrike
CRWD
$104B
| $15.3M | 3.15% |
43,302
-62,953
| -59% | -$22.2M |
|
12
Applied Materials
AMAT
$126B
| $14.8M | 3.05% |
102,009
-42,092
| -29% | -$6.11M |
|
13
SentinelOne
S
$5.9B
| $14.5M | 3% |
799,521
+104,182
| +15% | +$1.89M |
|
14
Alphabet (Google) Class C
GOOG
$2.56T
| $13.5M | 2.79% |
86,519
-152,007
| -64% | -$23.7M |
|
|
SWTX
15
DELISTED
SpringWorks Therapeutics
SWTX
| $12.4M | 2.57% |
+282,105
| New | +$12.4M |
|
16
Amphenol
APH
$133B
| $10.7M | 2.22% |
+163,806
| New | +$10.7M |
|
17
Janux Therapeutics
JANX
$1.37B
| $10.2M | 2.1% |
376,496
-52,896
| -12% | -$1.43M |
|
18
Scholar Rock
SRRK
$3.18B
| $10.1M | 2.08% |
313,689
-72,236
| -19% | -$2.32M |
|
19
Procter & Gamble
PG
$370B
| $7.77M | 1.6% |
45,570
+42,679
| +1,476% | +$7.27M |
|
20
Coca-Cola
KO
$297B
| $7.69M | 1.59% |
107,440
+101,689
| +1,768% | +$7.28M |
|
21
PepsiCo
PEP
$206B
| $7.24M | 1.49% |
48,298
+44,397
| +1,138% | +$6.66M |
|
22
Fiserv
FI
$74.4B
| $6.5M | 1.34% |
29,423
-99,577
| -77% | -$22M |
|
23
Cytokinetics
CYTK
$5.94B
| $6.48M | 1.34% |
161,285
-167,851
| -51% | -$6.75M |
|
24
Neurocrine Biosciences
NBIX
$14.1B
| $5.97M | 1.23% |
53,954
| – | – |
|
25
Viridian Therapeutics
VRDN
$1.56B
| $5.71M | 1.18% |
423,272
| – | – |
|